This is an observational trial that will look at patients undergoing endoscopic ultrasound (EUS) in patients with oesophageal cancer and to determine the proportion of cases in which EUS changes disease management in these patients.
Patients aged 16 or above with first diagnosis of biopsy-confirmed oesophageal cancer.
Referred for EUS examination as part of standard of care investigations.
Tumour location in the oesophagus, or gastro-oesophageal junction (Siewert types I-III)
MDT decision that patient is potentially curable with radical treatment (e.g., endoscopic treatment, surgery +/- neoadjuvant therapy, or definitive chemoradiotherapy)
Recurrent or residual disease
Distant metastatic disease detected before EUS.
Previous oesophagectomy or oesophageal radiotherapy
Unable to undergo EUS examination.
University Hospital Southampton NHS Foundation Trust
Lead sponsor
National Institute for Health Research, United Kingdom
Collaborator